This inventor holds 7 USPTO granted patents and 7 published patent applications. Top assignee: The Wistar Institute. Active years: 2017-2026.
Company Filing History:
Years Active: 2017-2026
Title: Innovations and Contributions of Xiang Yang Zhou
Introduction
Xiang Yang Zhou is a notable inventor based in North Wales, PA (US). He has made significant contributions to the field of vaccine development and gene therapy. With a total of 7 patents, Zhou's work has the potential to impact both veterinary and human medicine.
Latest Patents
Among his latest patents is the "Melanoma Canine Vaccine Compositions and Methods of Use Thereof." This innovative work focuses on developing a vaccine for melanoma in dogs, showcasing his commitment to improving animal health. Another significant patent is related to "Adenoviral vectors comprising partial deletions of E3." This disclosure provides replication-incompetent adenoviral vectors that are useful in vaccine development and gene therapy. The vectors feature a selective deletion of E3, making them particularly valuable for preparing vaccines and for gene therapy involving toxic transgene products.
Career Highlights
Xiang Yang Zhou is affiliated with The Wistar Institute, a prominent research institution known for its contributions to biomedical research. His work at the institute has allowed him to explore innovative solutions in the field of immunology and gene therapy.
Collaborations
Zhou has collaborated with notable colleagues, including Hildegund C J Ertl and Hildegund C Ertl, who have also made significant contributions to the field. Their joint efforts have further advanced research in vaccine development and gene therapy.
Conclusion
Xiang Yang Zhou's innovative work and patents reflect his dedication to advancing medical science. His contributions, particularly in vaccine development and gene therapy, hold promise for both animal and human health.